» Authors » H J Deeg

H J Deeg

Explore the profile of H J Deeg including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 424
Citations 5526
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Deeg H, Moutou C, Erikson A, Csizmadia S, Tingley B, Barge P, et al.
Nature . 2010 Mar; 464(7287):384-7. PMID: 20237564
Of the over 400 known exoplanets, there are about 70 planets that transit their central star, a situation that permits the derivation of their basic parameters and facilitates investigations of...
12.
Armand P, Deeg H, Kim H, Lee H, Armistead P, de Lima M, et al.
Bone Marrow Transplant . 2009 Sep; 45(5):877-85. PMID: 19784076
Cytogenetics is an important prognostic factor for patients with myelodysplastic syndromes (MDS). However, existing cytogenetics grouping schemes are based on patients treated with supportive care, and may not be optimal...
13.
Furlong T, MARTIN P, Flowers M, Carnevale-Schianca F, Yatscoff R, Chauncey T, et al.
Bone Marrow Transplant . 2009 Apr; 44(11):739-48. PMID: 19377515
We evaluated the pharmacokinetics and efficacy of oral mycophenolate mofetil (MMF) for treatment of refractory GVHD. In a prospective study of acute GVHD, 9 of 19 patients (47%) had a...
14.
Campregher P, Gooley T, Scott B, Moravec C, Sandmaier B, Martin P, et al.
Bone Marrow Transplant . 2007 Sep; 40(10):965-71. PMID: 17846603
Allogeneic hematopoietic cell transplantation (HCT) represents a potentially curative approach for patients with myelodysplastic syndromes (MDSs). While a large proportion of HCT recipients become long-term disease-free survivors, recurrence of MDS...
15.
Ying S, Seal S, Abbassi N, Hockenbery D, Kiem H, Li X, et al.
Leuk Lymphoma . 2007 May; 48(5):1003-14. PMID: 17487744
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces programmed cell death (apoptosis) preferentially in tumor cells. However, not all cancer cells are sensitive to TRAIL. We determined whether ligation of the...
16.
Deeg H, Maris M, Scott B, Warren E
Leukemia . 2006 Aug; 20(10):1701-5. PMID: 16888618
Numerous reduced-intensity conditioning regimens for allogeneic hematopoietic cell transplantation are currently being explored, primarily in older patients and in individuals with comorbid conditions who are not eligible for conventional myeloablative...
17.
Lesnikov V, Abbasi N, Lesnikova M, Lazaro C, Campbell J, Fausto N, et al.
Apoptosis . 2005 Dec; 11(1):79-87. PMID: 16374550
Recent studies in a murine model show that transferrin (Tf) interferes with Fas-mediated hepatocyte death and liver failure by decreasing pro-apoptotic and increasing anti-apoptotic signals. We show here in vitro...
18.
Scott B, Sandmaier B, Storer B, Maris M, Sorror M, Maloney D, et al.
Leukemia . 2005 Nov; 20(1):128-35. PMID: 16270037
Transplant outcome was analyzed in 150 patients with myelodysplastic syndrome (MDS) or acute myelogenous leukemia transformed from MDS (tAML) conditioned with nonmyeloablative or myeloablative regimens. A total of 38 patients...
19.
Zanis-Neto J, Flowers M, Medeiros C, Bitencourt M, Bonfim C, Setubal D, et al.
Br J Haematol . 2005 Jun; 130(1):99-106. PMID: 15982351
Allogeneic haematopoietic cell transplantation (HCT) is effective therapy for Fanconi anaemia (FA). FA patients do not tolerate conditioning with 200 mg/kg of cyclophosphamide (Cy), typically used in aplastic anaemia. We...
20.
Wilson H, Lesnikov V, Plymate S, Ward J, Deeg H
Leukemia . 2005 Feb; 19(4):580-5. PMID: 15703779
The pathophysiology of the myelodysplastic syndromes (MDS) is incompletely understood. Tumor necrosis factor (TNF)alpha levels are elevated, particularly in early-stage MDS, and apoptosis in marrow cells is upregulated. Observations in...